CD8A and hepatocellular carcinoma: Consistent with the anti-tumor effects we observed in the tumor-bearing db/db diabetic mice﻿, patients with a high ratio of intra-tumoral CD8+ T lymphocytes with activated CTLs to Tregs were associated with a more favorable clinical outcome in both hepatocellular carcinoma and ovarian cancer26, 27.